Soluble HLA class I in epithelial lining fluid of lung transplants: Associations with graft outcome

Human Immunology

Volumn 52, Issue 2, 1997, Pages 95-108

  Devito Haynes, Lynn D ^a   Jankowska Gan, Ewa ^a   Heisey, Dennis M ^a   Cornwell, Richard D ^a   Meyer, Keith C ^a   Love, Robert B ^a   Burlingham, William J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; GRAFT REJECTION; GRAFT SURVIVAL; HLA SYSTEM; HUMAN; LUNG LAVAGE; LUNG TRANSPLANTATION; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM;

ACUTE DISEASE; BODY FLUIDS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOMEGALOVIRUS INFECTIONS; EPITHELIUM; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LEUKOCYTE COUNT; LUNG TRANSPLANTATION; NEUTROPHILS; PROGNOSIS; SOLUBILITY;

EID: 0030903867     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(96)00286-8     Document Type: Article

References (61)

1. Shoskes DA, Wood KJ: Indirect presentation of MHC antigens in transplantation. Immunol Today 15:32, 1994.
2. Steinhoff G, Wonigeit K, Schafers HJ, Haverich A: Sequential analysis of monomorphic and polymorphic major histocompatibility complex antigen expression in human heart allograft biopsy specimens. J Heart Transplant 8: 360, 1989.
3. Sell KW, Tadros T, Wang YC: Studies of major histocompatibility complex class I/II expression on sequential human heart biopsy specimens after transplantation. J Heart Transplant 7:407, 1988.
4. von Willebrand E, Salmela K, Isoniemi H, Krogerus L, Taskinen E, Hayry PJ: Induction of HLA class II antigen and interleukin 2 receptor expression in acute vascular rejection of human kidney allografts. Transplantation 53: 1077, 1992.
5. Haga JA, She JX, Kao KJ: Biochemical characterization of 39-kDa class I histocompatibility antigen in plasma: A secretable membrane protein derived from transmembrane domain deletion. J Biol Chem 266:3695, 1991.
6. Brieva JA, Villar LM, Leoro G, Alvarez-Cermeno JC, Roldan E, Gonzalez-Porque P: Soluble HLA class I antigen secretion by normal lymphocytes: Relationship with cell activation and effect of interferon-γ. Clin Exp Immunol 82:390, 1990.
7. Demaria S, Schwab R, Gottesman SRS, Bushkin Y: Soluble β2microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease. J Biol Chem 269:6689, 1994.
8. He X, Le J: Alternative splicing of HLA class I transcripts induced by IFN-γ and TNF in fibroblasts: Release of soluble HLA class I heavy chain and an associate protein. Cell Immunol 162:159, 1995.
9. Tilg H, Westhoff U, Vogel W, Aulitzky WE, Herold M, Margreiter R, Huber C, Grosse-Wilde H: Soluble HLA class I serum concentrations increase with transplant-related complications after liver transplantation. J Hepatol 14:417, 1992.
10. Zavazava N, Bottcher H, Ruchholtz WM: Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens 42:20, 1993.
11. Puppo F, Pellicci R, Brenci S, Nocera A, Morelli N, Dardano G, Bertocchi M, Antonucci A, Ghio M, Scudeletti M, Barocci S, Valente U, Indiveri F: HLA class-I-soluble antigen serum levels in liver transplantation: A predictor marker of acute rejection. Hum Immunol 40:166, 1994.
12. DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ: Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol 40:191, 1994.
13. DeVito-Haynes LD, Jankowska-Gan E, Heisey D, Jutte NHPM, Balk AHMM, Weimar W, Claas FHJ, Warner TFC, Mentzer RM, Love RB, Burlingham WJ: Donor-derived HLA class I proteins in the serum of heart transplant recipients. J Heart Lung Transplant 15:1012, 1996.
14. Burlingham WJ, Fechner JH, DeVito LD, Sollinger HW, Knechtle SJ, Grailer AP: Human interleukin-2 and lymphoproliferative (T-helper cell) responses to soluble HLA class I antigens in vitro: I. Specificity for polymorphic domains. Tissue Antigens 42:35, 1993.
15. Hausmann R, Zavazava N, Steinmann J, Mueller-Ruchholtz W: Interaction of papain-digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL). Clin Exp Immunol 91:183, 1993.
16. Zavazava N, Kronke M: Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nature Med 2:1005, 1996.
17. Valentine VG, Robbins RC, Berry GJ, Patel HR, Reichenspurner H, Reitz BA, Theodore J: Actuarial survival of heart lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 15:371, 1996.
18. Hosenpud JD, Novick RJ, Bennett LE, Keck BM, Fiol B, Daily OP: The registry of the international society for heart and lung transplantation: Thirteenth official report - 1996. J Heart Lung Transplant 15:655, 1996.
19. King TE, Jr: The handling and analysis of bronchoalveolar lavage specimens. In Baughman RP (ed): Bronchoalveolar Lavage, St. Louis: Mosby-Year Book, Inc., 1992, p 3.
20. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin PG, Crystal RG: Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 60:532, 1986.
21. The BAL Cooperative Steering Committee: Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 141:S169, 1990.
22. Stanley MW, Henry-Stanley MJ, Iber C. Bronchoalveolar lavage. Cytology and clinical applications. New York: Igaku-Shoin Medical Publishers, Inc., 1991. p. 127.
23. Meyer K, Crabtree D, Cornwell R, Love R: Neutrophils and neutrophil mediators in lung transplantation. Am J Respir Crit Care Med 151:A256, 1995.
24. Reynaud-Gaubert M, Thomas P, Brunet C, Dumon JF, Garbe L, Badier M, Magnan A, Noirclerc M, Giudicelli R, Fuentes P: Cells profiles and immunophenotyping of lymphocyte subsets in bronchoalveolar lavage fluid (BAL) after lung transplantation (LT). Am J Respir Crit Care Med 153:A154, 1996.
25. Dauber JH, Paradis IL, Duncan SR, Yousem SA. Pulmonary Transplantation. In Baughman RP (ed): Bronchoalveolar lavage, St. Louis: Mosby-Year Book, Inc., 1992. p 3.
26. Glanville AR, Tazelaar HD, Theodore J, Imoto E, Rouse RV, Baldwin JC, Robin ED: The distribution of MHC class I and II antigens on bronchial epithelium. Am Rev Respir Dis 139:330, 1989.
27. Pabst R: Is BALT a major component of the human lung immune system? Immunol Today 13:119, 1992.
28. Zeevi A, Dauber JH, Yousem SA, Keenan RJ, Paradis I, Griffith BP, Duquesnoy RJ. Immunologic alterations in chronic lung rejection. In Shennib H (ed): Immunology of lung allograft, Austin: R.G. Landes Company, 1995, p 73.
29. Meyer KC, Zimmerman J: Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis. J Lab Clin Med 121:654, 1993.
30. Yousem SA, Berry GJ, Brunt EM: A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung rejection study group. J Heart Lung Transplant 9:593, 1990.
31. Peterson GL: A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:346, 1977.
32. Tanabe M, Sekimata M, Ferrone S, Takiguchi M: Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reactive with the HLA Class I α3 domain. J Immunol 148:3202, 1992.
33. Tsujisaki M, Sakaguchi K, Igarashi M, Richiardi P, Perosa F, Ferrone S: Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1. Transplantation 45:632, 1988.
34. McMichael AJ, Parham P, Rust N, Brodsky FM: A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17. Hum Immunol 1:121, 1980.
35. Parham P: Monoclonal antibodies against two separate alloantigenic sites of HLA-B40. Immunogenetics 13:509, 1981.
36. El-Zaatari FAK, Taurog JD: In vitro mutagenesis of HLA-B27: Single and multiple amino acid substitutions at consensus B27 sites identify distinct monoclonal antibody-defined epitopes. Hum Immunol 33:243, 1992.
37. Smith ME, Marsh SG, Bodmer JG, Gelsthorpe K, Bodmer WF: Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia. Proc Natl Acad Sci USA 86:5557, 1989.
38. Hiraki DD, See-Tho K, Filvaroff E, Krishnaswamy S, de Bello W, Taidi-Laskowski B, Grumet FC: Bioengineered soluble HLA-B7. Genesis, characterization, and occurrence of dimerization. Hum Immunol 40:235, 1994.
39. b fusion protein. Hum Immunol 32:125, 1991.
40. SAS Institute Inc., SAS/STAT user's Guide, Version 6, Cary: SAS institute Inc., 1989. p. 846.
41. Nguyen DM, Shennib H. Early immunological events in the lung allograft. In: Shennib H. ed Immunology of lung allograft, Austin: R.G. Landes Company, 1995, p. 1.
42. McDonald JC, Gelder FB, Aultman DF, Landreneau MD, McMillan RW, Singh I, Sorrells D, Liou W-H: HLA in human serum - Quantitation of Class I by enzyme immunoassay. Transplantation 53:445, 1992.
43. Pouletty P, Ferrone S, Amesland F, Cohen N, Westhoff U, Charron D, Shimizu RM, Grosse-Wilde H: Summary report from the First International Workshop on Soluble HLA Antigens. Paris, August 1992. Tissue Antigens 42: 45, 1993.
44. Grumet FC, Krishnaswamy S, See-Tho K, Filvaroff E, Hiraki DD: Soluble form of a HLA-B7 class I antigen specifically suppresses humoral alloimmunization. Hum Immunol 40:228, 1994.
45. d in animals transgenic for its soluble analog. Hum Immunol 52:82-94, 1997. (this issue)
46. Arnold B, Dill O, Kublbeck G, Jatsch L, Simon MM, Tucker J, Hammerling GJ: Alloreactive immune responses of transgenic mice expressing a foreign transplantation antigen in a soluble form. Proc Natl Acad Sci USA 85:2269, 1988.
47. Arnold B, Messerle M, Jatsch L, Kublbeck G, Koszinowski U: Transgenic mice expressing a soluble foreign H-2 class antigen are tolerant to allogeneic fragments presented by self class I but not to the whole membrane-bound alloantigen. Proc Natl Acad Sci USA 87:1762, 1990.
48. Allison JP, Pellegrino MA, Ferrone S, Callahan GIV, Reisfeld RA: Biologic and chemical characterization of HLA antigens in human serum. J Immunol 118:1004, 1977.
49. Krangel MS: Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med 163:1173, 1986.
50. Tambutti ML, Ferraris JR, Redal MA, Ramirez JA, Prigoshin M: Soluble HLA class I antigens in pediatric patients with renal transplants from related living donors without acute rejection and treated with triple therapy. Hum Immunol 50:135, 1996.
51. Aulitzky WE, Grosse-Wilde H, Westhoff U, Tilg H, Aulitzky W, Gastl G, Herold M, Huber C: Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-γ). Clin Exp Immunol 86:236, 1991.
52. Burlingham WJ, Grailer AP, Fechner JH Jr, Kusaka S, Trucco M, Kocova M, Belzer FO, Sollinger HW: Microchimerism linked to cytotoxic T lymphocytes unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation 59:1147, 1995.
53. Starzl TE, Demetris AJ, Trucco M, Zeevi A, Ramos H, Terasaki P, Rudert WA, Kocova M, Ricordi C, Ildstad S, Murase N: Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 55:1272, 1993.
54. Reinsmoen NL, Jackson A, McSherry C, Ninova D, Wiesner RH, Kondo M, Krom RA, Hertz MI, Bolman RM, Matas AJ: Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. Transplantation 60:1546, 1995.
55. Kao KJ, Shieh DC: Proportional amplification of individual HLA-A and -B antigens during upregulated expression of total class I HLA molecules. Hum Immunol 42:174, 1995.
56. Kwon OJ, Au BT, Collins PD, Adcock IM, Mak JC, Robbins RR, Chung KF, Barnes PJ: Tumor necrosis factor-induced interleukin-8 expression in cultured human airway epithelial cells. Am J Physiol 267:L398, 1994.
57. Smart SJ, Casale TB: TNF-alpha-induced transendothelial neutrophil migration is IL-8 dependent. Am J Physiol 266:L238, 1994.
58. Monti G, Magnan A, Fattal M, Rain B, Humbert M, Mege J-L, Noirclerc M, Dartevelle P, Cerrina J, Simonneau G, Galgnaud P, Emilie D: Intrapulmonary production of RANTES during rejection and CMV pneumonitis after lung transplantation. Transplantation 61:1757, 1996.
59. Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran PF: Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Analysis using the Banff grading schema. Transplantation 61: 1586, 1996.
60. Suciu-Foca N, Reed E, Marboe C, Harris P, Xi YP, Yu-Kai S, Ho E, Rose E, Reemtsma K, King DW: The role of anti-HLA antibodies in heart transplantation. Transplantation 51:716, 1991.
61. Cherry R, Nielsen H, Reed E, Reemtsma K, Suciu-Foca N, Marboe CC: Vascular (humoral) rejection in human cardiac allograft biopsies: Relation to circulating anti-HLA antibodies. J Heart Lung Transplant 11:24, 1992.